To identify potential regulators and target genes of aberrantly expressed IRX3 and IRX5, we then compared RNA-seq data from IRX3/IRX5-positive with IRX1-positive AML cell lines (Table S2). The gene discussed is IRX1; the disease is acute myeloid leukemia.